Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Active not recruiting 3Completed 2Unknown 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Breast 1

Conditions

Ovarian Neoplasms 2Hereditary Breast and Ovarian Cancer Syndrome 1

Interventions

pembrolizumab 439Carboplatin 323Nivolumab 291Cyclophosphamide 281Specimen Handling 271Magnetic Resonance Spectroscopy 257Cisplatin 254Paclitaxel 249Radiotherapy 229Gemcitabine 183Biopsy 182Dexamethasone 181durvalumab 169atezolizumab 151Rituximab 138Doxorubicin 135Lenalidomide 134Bevacizumab 133Docetaxel 131Ipilimumab 129Capecitabine 120Radiation 118Radiosurgery 114Oxaliplatin 114Pemetrexed 113Etoposide 111Fluorouracil 110venetoclax 108fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Salpingectomy × Clear all
NCT03045965 2026-02-17

HOPPSA

Göteborg University

Phase NA Active not recruiting
4,400 enrolled
Gynecologic

Ovarian Neoplasms

NCT02760849 2026-01-07

Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations

M.D. Anderson Cancer Center

Phase NA Active not recruiting
374 enrolled
BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

NCT02321228 2024-12-05

TUBA

University Medical Center Nijmegen

Phase NA Active not recruiting
510 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡